/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-21-09-53-38-217-67dd3722f016db2f4cd15c95.jpg)
Various UK pharmaceutical companies yesterday co-signed a report warning that future UK investment is unlikely unless the Government...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-17-14-22-08-450-67d830102c113a118a323c20.jpg)
On Friday, the DHSC published the latest consultation to update the repayment percentage under the Statutory Scheme. This consultation...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-03-12-14-32-10-309-67d19aea5746d2ef9a9b9626.jpg)
HMRC has been granted permission to appeal the First-Tier Tribunal’s VAT decision in the case of Boehringer Ingelheim Ltd v HMRC. We...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2025-02-11-12-00-16-385-67ab3bd0c56e29c3df61c085.jpg)
The MHRA and NICE published guidance on “Digital mental health technology: qualification and classification” (the DMHT Guidance) last...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-12-19-12-21-24-651-67640fc43e67bad811f6af68.jpg)
On 16 December, the DHSC announced that the 2025 headline VPAG repayment percentage for sales of “newer medicines” will be 22.9%. This...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-12-12-11-49-56-681-675acde4d71c143dca66c43d.jpg)
In London last week, over 400 attendees and speakers gathered together for the fifth annual SynbiTECH conference in London. The event...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-27-13-31-57-450-67471f4da72c76483c179ddf.jpg)
The Terminally Ill Adults (End of Life) Bill, introduced as a private members’ bill by Kim Leadbeater MP on 11 November 2024 (Leadbeater...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-25-13-06-04-849-6744763c8416027180e3c559.jpg)
The consultation on the future of the UK’s Medical Devices Regulations 2002 (UK MDR), initiated by the MHRA on 14 November 2024,...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-25-12-31-51-338-67446e378416027180e3b6f7.jpg)
Background The MHRA has launched a Consultation on future changes to the UK Medical Devices Regulations. The consultation addresses four...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-22-14-48-09-637-674099a9f07133d089d44399.jpg)
As briefly mentioned in our article last week on Priority Review Vouchers, the financial terms of a biopharma patent licence agreement...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-19-13-33-35-541-673c93af3578d9951b12158b.jpg)
We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...
/Passle/5f3d6e345354880e28b1fb63/SearchServiceImages/2024-11-11-09-37-20-109-6731d050fd2cf13c413282c5.jpg)
On 5 November 2024, Acadia Pharmaceuticals Inc. ("Acadia") announced that it sold its rare paediatric disease priority review voucher...